"PPD is a clinical research facility located in Austin, TX, recruiting generally healthy volunteers 18 and older to participate in clinical trials, and financially compensating them for participation. Some of these studies are outpatient or even at-home trials, while others require a stay at our facility. To learn more or to see if you qualify for an Austin research study, call PPD today for a confidential conversation."

During the past decade, PPD Phase I Clinic conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 4 clinical trials were completed, i.e. on average, 8.9% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 2 clinical trials were completed. i.e. 9.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PPD Phase I Clinic" #1 sponsor was "Celgene" with 14 trials, followed by "Bristol-Myers Squibb" with 8 trials sponsored, "Enanta Pharmaceuticals, Inc" with 4 trials sponsored, "Tetraphase Pharmaceuticals, Inc." with 4 trials sponsored and "SIGA Technologies" with 4 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PPD Phase I Clinic" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials as a collaborator, "PPD" with 3 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 2 trials as a collaborator, "Impact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation" with 2 trials as a collaborator and "ARMO BioSciences" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "PPD Phase I Clinic" are "Healthy Volunteers" (17 trials), "Healthy" (9 trials), "Healthy Volunteer" (6 trials), "Bacterial Infections" (4 trials) and "Smallpox" (3 trials). Many other conditions were trialed in "PPD Phase I Clinic" in a lesser frequency.

Most popular intervention types in "PPD Phase I Clinic" are "Drug" (57 trials), "Other" (8 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "TP-271" (4 trials), "BMS-986205" (3 trials), "Moxifloxacin" (3 trials) and "ARRY-371797, p38 inhibitor; oral" (2 trials). Other intervention names were less common.

The vast majority of trials in "PPD Phase I Clinic" are 57 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "PPD Phase I Clinic". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in PPD Phase I Clinic, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in PPD Phase I Clinic, 50 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".